Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Colleen McIlvennan to Heart Failure

This is a "connection" page, showing publications Colleen McIlvennan has written about Heart Failure.

 
Connection Strength
  
 
 
8.515
  
  1. McIlvennan CK, Jones J, Makic M, Meek PM, Chaussee E, Thompson JS, Matlock DD, Allen LA. Stress and Coping Among Family Caregivers of Patients With a Destination Therapy Left Ventricular Assist Device: A Multicenter Mixed Methods Study. Circ Heart Fail. 2021 10; 14(10):e008243.
    View in: PubMed
    Score: 0.325
  2. Fraser MT, Mcilvennan CK. Reorienting Ourselves to Delirium: Caring for Older Patients Hospitalized With Heart Failure. J Card Fail. 2021 04; 27(4):460-463.
    View in: PubMed
    Score: 0.316
  3. McIlvennan CK, Allen LA, Devore AD, Granger CB, Kaltenbach LA, Granger BB. Changes in Care Delivery for Patients With Heart Failure During the COVID-19 Pandemic: Results of a Multicenter Survey. J Card Fail. 2020 07; 26(7):635-636.
    View in: PubMed
    Score: 0.298
  4. McIlvennan CK, Matlock DD, Allen LA, Thompson JS, Ranby KW, Sannes TS. Perceived Stress and Depressive Symptoms as Predictors of Decisional Conflict in Dyads Considering a Left Ventricular Assist Device. Circ Cardiovasc Qual Outcomes. 2020 03; 13(3):e006155.
    View in: PubMed
    Score: 0.294
  5. McIlvennan CK, Benton EM, Allen LA. Educate, Engage, Empower: Leveraging Technology to Promote Learning in Patients Implanted With a Left Ventricular Assist Device and Their Caregivers. Circ Cardiovasc Qual Outcomes. 2019 10; 12(10):e006107.
    View in: PubMed
    Score: 0.285
  6. McIlvennan CK, Matlock DD. "Have You Ever Seen That Movie Misery?" Time to Think Outside the Box to Help Caregivers of Patients With Left Ventricular Assist Devices. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e005454.
    View in: PubMed
    Score: 0.270
  7. McIlvennan CK, Grady KL, Matlock DD, Helmkamp LJ, Abshire M, Allen LA. End of life for patients with left ventricular assist devices: Insights from INTERMACS. J Heart Lung Transplant. 2019 04; 38(4):374-381.
    View in: PubMed
    Score: 0.270
  8. McIlvennan CK. Improving Decision Making for Advanced Heart Failure Patients and Caregivers. J Nurs Adm. 2017 Apr; 47(4):190-191.
    View in: PubMed
    Score: 0.239
  9. McIlvennan CK, Matlock DD. Palliative Care in Heart Failure: Architects Needed. J Card Fail. 2017 02; 23(2):201-203.
    View in: PubMed
    Score: 0.234
  10. McIlvennan CK, Wordingham SE, Allen LA, Matlock DD, Jones J, Dunlay SM, Swetz KM. Deactivation of Left Ventricular Assist Devices: Differing Perspectives of Cardiology and Hospice/Palliative Medicine Clinicians. J Card Fail. 2017 Sep; 23(9):708-712.
    View in: PubMed
    Score: 0.234
  11. McIlvennan CK, Page RL. Foundations of Pharmacotherapy for Heart Failure With Reduced Ejection Fraction: Evidence Meets Practice, Part II. J Cardiovasc Nurs. 2016 Nov/Dec; 31(6):545-554.
    View in: PubMed
    Score: 0.233
  12. McIlvennan CK, Thompson JS, Matlock DD, Cleveland JC, Dunlay SM, LaRue SJ, Lewis EF, Patel CB, Walsh MN, Allen LA. A Multicenter Trial of a Shared Decision Support Intervention for Patients and Their Caregivers Offered Destination Therapy for Advanced Heart Failure: DECIDE-LVAD: Rationale, Design, and Pilot Data. J Cardiovasc Nurs. 2016 Nov/Dec; 31(6):E8-E20.
    View in: PubMed
    Score: 0.233
  13. McIlvennan CK, Lindenfeld J, Kao DP. Sex differences and in-hospital outcomes in patients undergoing mechanical circulatory support implantation. J Heart Lung Transplant. 2017 01; 36(1):82-90.
    View in: PubMed
    Score: 0.230
  14. Allen LA, McIlvennan CK. Predicting in-hospital worsening heart failure at time of admission, but do we really need another heart failure risk model? Am Heart J. 2016 08; 178:188-9.
    View in: PubMed
    Score: 0.226
  15. Bui QM, Allen LA, Monte AA, Page RL, McIlvennan CK. Amphetamine-positive urine drug screens in the setting of mexiletine use: A case series. J Heart Lung Transplant. 2016 08; 35(8):1045-8.
    View in: PubMed
    Score: 0.225
  16. McIlvennan CK, Allen LA. Palliative care in patients with heart failure. BMJ. 2016 Apr 14; 353:i1010.
    View in: PubMed
    Score: 0.224
  17. McIlvennan CK, Jones J, Allen LA, Swetz KM, Nowels C, Matlock DD. Bereaved Caregiver Perspectives on the End-of-Life Experience of Patients With a Left Ventricular Assist Device. JAMA Intern Med. 2016 Apr; 176(4):534-9.
    View in: PubMed
    Score: 0.223
  18. McIlvennan CK, Allen LA. Quality of Life After Left Ventricular Assist Device Implantation: In a World Full of Data, #Missingness. J Card Fail. 2016 05; 22(5):338-9.
    View in: PubMed
    Score: 0.221
  19. McIlvennan CK, Jones J, Allen LA, Lindenfeld J, Swetz KM, Nowels C, Matlock DD. Decision-making for destination therapy left ventricular assist devices: implications for caregivers. Circ Cardiovasc Qual Outcomes. 2015 Mar; 8(2):172-8.
    View in: PubMed
    Score: 0.208
  20. McIlvennan CK, Matlock DD, Narayan MP, Nowels C, Thompson JS, Cannon A, Bradley WJ, Allen LA. Perspectives from mechanical circulatory support coordinators on the pre-implantation decision process for destination therapy left ventricular assist devices. Heart Lung. 2015 May-Jun; 44(3):219-24.
    View in: PubMed
    Score: 0.207
  21. McIlvennan CK, Allen LA. Outcomes in acute heart failure: 30-day readmission versus death. Curr Heart Fail Rep. 2014 Dec; 11(4):445-52.
    View in: PubMed
    Score: 0.204
  22. McIlvennan CK, Magid KH, Ambardekar AV, Thompson JS, Matlock DD, Allen LA. Clinical outcomes after continuous-flow left ventricular assist device: a systematic review. Circ Heart Fail. 2014 Nov; 7(6):1003-13.
    View in: PubMed
    Score: 0.202
  23. McIlvennan CK, Page RL, Ambardekar AV, Brieke A, Lindenfeld J. Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients. J Heart Lung Transplant. 2014 Dec; 33(12):1312-4.
    View in: PubMed
    Score: 0.201
  24. Kim JM, Maqsood MH, Makuvire T, McIlvennan CK, Thompson JS, Matlock DD, Allen LA, Warraich HJ. Gender-based differences in decision making, quality of life and survival among patients undergoing left ventricular assist device evaluation. PLoS One. 2023; 18(10):e0293121.
    View in: PubMed
    Score: 0.094
  25. Swat SA, Helmkamp LJ, Tietbohl C, Thompson JS, Fitzgerald M, McIlvennan CK, Harger G, Ho PM, Ahmad FS, Ahmad T, Buttrick P, Allen LA. Clinical Inertia Among Outpatients With?Heart?Failure: Application of Treatment Nonintensification Taxonomy to?EPIC-HF Trial. JACC Heart Fail. 2023 11; 11(11):1579-1591.
    View in: PubMed
    Score: 0.093
  26. Grady KL, Kallen MA, Beiser DG, Lindenfeld J, Teuteberg J, Allen LA, McIlvennan CK, Rich J, Yancy C, Lee CS, Denfeld QE, Kiernan M, Walsh MN, Adler E, Ruo B, Stehlik J, Kirklin JK, Bedjeti K, Cella D, Hahn EA. Novel measures to assess ventricular assist device patient-reported outcomes: Findings from the MCS A-QOL study. J Heart Lung Transplant. 2024 Jan; 43(1):36-50.
    View in: PubMed
    Score: 0.093
  27. Bechthold AC, Knoepke CE, Ejem DB, McIlvennan CK, Wells RD, Matlock DD, Bakitas MA, Dionne-Odom JN. How Values Are Discussed, Reflected Upon, and Acted On by Patients and Family Caregivers in the Context of Heart Failure: A Scoping Review. Med Decis Making. 2023 05; 43(4):508-520.
    View in: PubMed
    Score: 0.091
  28. Bui CM, Schneider LM, Brown MR, Char DS, McIlvennan CK, Hollander SA. Bereaved Caregiver Perspectives on the End of Life in Pediatric Patients With Ventricular Assist Devices. Pediatr Crit Care Med. 2022 12 01; 23(12):e601-e606.
    View in: PubMed
    Score: 0.088
  29. Venechuk G, Allen LA, Thompson JS, Morris MA, Matlock DD, McIlvennan CK, Dickert NW, Tietbohl C. Trust and activation in defining patient-clinician interactions for chronic disease management. Patient Educ Couns. 2023 Jan; 106:113-119.
    View in: PubMed
    Score: 0.088
  30. Baik D, McIlvennan CK, Baker C, Coats H. Caregiving experiences of older family caregivers of persons with heart failure: A mixed methods study. Geriatr Nurs. 2022 Nov-Dec; 48:51-57.
    View in: PubMed
    Score: 0.087
  31. Haynes JE, Matlock DD, Thompson JS, Mosley BS, Fitzgerald MD, McIlvennan CK, Allen LA. "Would You Get a Destination Therapy Left Ventricular Assist Device?": Health Care Workers' Views on a Preference-Sensitive Decision. Circ Heart Fail. 2022 12; 15(12):e009626.
    View in: PubMed
    Score: 0.087
  32. Knoepke CE, Siry-Bove B, Mayton C, Latimer A, Hart J, Allen LA, Daugherty SL, McIlvennan CK, Matlock DD, Khazanie P. Variation in Left Ventricular Assist Device Postdischarge Caregiver Requirements: Results From a Mixed-Methods Study With Equity Implications. Circ Heart Fail. 2022 08; 15(8):e009583.
    View in: PubMed
    Score: 0.086
  33. Raymer DS, Allen LA, Chaussee EL, McIlvennan CK, Thompson JS, Fairclough DL, Dunlay SM, Matlock DD, Larue SJ. Health Literacy in Patients Considering a Left Ventricular Assist Device: Findings From the DECIDE-LVAD Trial. J Card Fail. 2022 08; 28(8):1318-1325.
    View in: PubMed
    Score: 0.085
  34. Fraser M, McIlvennan CK, Joseph N, Alexy T. From the Other Side of the Exam Room: Using the New Universal Definition and Classification of Heart Failure to Engage Patients and Caregivers. J Card Fail. 2023 09; 29(9):1338-1339.
    View in: PubMed
    Score: 0.084
  35. Knoepke CE, Chaussee EL, Matlock DD, Thompson JS, McIlvennan CK, Ambardekar AV, Schaffer EM, Khazanie P, Scherer L, Arnold RM, Allen LA. Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial. Med Decis Making. 2022 04; 42(3):404-414.
    View in: PubMed
    Score: 0.081
  36. Kanwar MK, McIlvennan CK, Lohmueller LC, Bailey SH, Rogers JG, Teuteberg J, Cowger J. Defining Optimal Outcomes in Patients with Left Ventricular Assist Devices. ASAIO J. 2021 04 01; 67(4):397-404.
    View in: PubMed
    Score: 0.079
  37. Thompson JS, Fitzgerald MD, Allen LA, McIlvennan CK, Glasgow RE, Wynia M, Morris MA, Beilenson J, Gherst C, Matlock DD. Shared Decision-Making for Left Ventricular Assist Devices: Rationale and Design of a Nationwide Dissemination and Implementation Project. Circ Cardiovasc Qual Outcomes. 2021 02; 14(2):e007256.
    View in: PubMed
    Score: 0.078
  38. Flint K, Chaussee EL, Henderson K, Breathett K, Khazanie P, Thompson JS, Mcilvennan CK, Larue SJ, Matlock DD, Allen LA. Social Determinants of Health and Rates of Implantation for Patients Considering Destination Therapy Left Ventricular Assist Device. J Card Fail. 2021 04; 27(4):497-500.
    View in: PubMed
    Score: 0.077
  39. Allen LA, Venechuk G, McIlvennan CK, Page RL, Knoepke CE, Helmkamp LJ, Khazanie P, Peterson PN, Pierce K, Harger G, Thompson JS, Dow TJ, Richards L, Huang J, Strader JR, Trinkley KE, Kao DP, Magid DJ, Buttrick PM, Matlock DD. An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF Trial. Circulation. 2021 02 02; 143(5):427-437.
    View in: PubMed
    Score: 0.077
  40. Venechuk GE, Khazanie P, Page RL, Knoepke CE, Helmkamp LJ, Peterson PN, Pierce K, Thompson JS, Huang J, Strader JR, Dow TJ, Richards L, Trinkley KE, Kao DP, McIlvennan CK, Magid DJ, Buttrick PM, Matlock DD, Allen LA. An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trial. Am Heart J. 2020 11; 229:144-155.
    View in: PubMed
    Score: 0.076
  41. Samsky MD, DeVore AD, McIlvennan CK, Granger CB, Granger BB, Hernandez AF, Felker GM, Fonarow GC, Albert NM, Pi?a IL, Lanfear D, Allen LA. Heart Failure Clinical Trial Operations During the COVID-19 Pandemic: Results From a Multicenter Survey. Circ Heart Fail. 2020 09; 13(9):e007456.
    View in: PubMed
    Score: 0.075
  42. Kitko L, McIlvennan CK, Bidwell JT, Dionne-Odom JN, Dunlay SM, Lewis LM, Meadows G, Sattler ELP, Schulz R, Str?mberg A. Family Caregiving for Individuals With Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2020 06 02; 141(22):e864-e878.
    View in: PubMed
    Score: 0.074
  43. Fendler TJ, McIlvennan CK, Matlock DD, Thompson JS, Chaussee EL, Dunlay SM, LaRue SJ, Raymer DS, Spertus JA, Lewis EF, Patel CB, Walsh MN, Allen LA. Exploring differences between patients who accept, decline, and are deemed ineligible for left ventricular assist device implantation as destination therapy. J Heart Lung Transplant. 2020 07; 39(7):721-724.
    View in: PubMed
    Score: 0.074
  44. Kanwar MK, Lohmueller LC, Teuteberg J, Kormos RL, Rogers JG, Benza RL, Lindenfeld J, McIlvennan C, Bailey SH, Murali S, Antaki JF. Risk Assessment in Patients with a Left Ventricular Assist Device Across INTERMACS Profiles Using Bayesian Analysis. ASAIO J. 2019 07; 65(5):436-441.
    View in: PubMed
    Score: 0.070
  45. Warraich HJ, Allen LA, Blue LJ, Chaussee EL, Thompson JS, McIlvennan CK, Flint KM, Matlock DD, Patel CB. Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study. Am Heart J. 2019 07; 213:91-96.
    View in: PubMed
    Score: 0.069
  46. Psotka MA, Ammon SE, Fiuzat M, Bozkurt B, Chung ES, Cole RT, Greene SJ, Kraus D, Ky B, McIlvennan CK, Shah P, Teerlink JR, Walsh MN, Jessup M, O'Connor CM. Heart Failure Site-Based Research in?the United States: Results of the Heart Failure Society of America Research?Network Survey. JACC Heart Fail. 2019 05; 7(5):431-438.
    View in: PubMed
    Score: 0.069
  47. McIlvennan CK, Matlock DD, Thompson JS, Dunlay SM, Blue L, LaRue SJ, Lewis EF, Patel CB, Fairclough DL, Leister EC, Swetz KM, Baldridge V, Walsh MN, Allen LA. Caregivers of Patients Considering a Destination Therapy Left Ventricular Assist Device and a Shared Decision-Making Intervention: The DECIDE-LVAD Trial. JACC Heart Fail. 2018 11; 6(11):904-913.
    View in: PubMed
    Score: 0.067
  48. Kanwar MK, Lohmueller LC, Kormos RL, Teuteberg JJ, Rogers JG, Lindenfeld J, Bailey SH, McIlvennan CK, Benza R, Murali S, Antaki J. A Bayesian Model to Predict Survival After Left Ventricular Assist Device Implantation. JACC Heart Fail. 2018 09; 6(9):771-779.
    View in: PubMed
    Score: 0.066
  49. Nizamic T, Murad MH, Allen LA, McIlvennan CK, Wordingham SE, Matlock DD, Dunlay SM. Ambulatory Inotrope Infusions in Advanced Heart Failure: A Systematic Review and Meta-Analysis. JACC Heart Fail. 2018 09; 6(9):757-767.
    View in: PubMed
    Score: 0.065
  50. Kwon R, Allen LA, Scherer LD, Thompson JS, Abdel-Maksoud MF, McIlvennan CK, Matlock DD. The Effect of Total Cost Information on Consumer Treatment Decisions: An Experimental Survey. Med Decis Making. 2018 07; 38(5):584-592.
    View in: PubMed
    Score: 0.065
  51. Allen LA, McIlvennan CK, Thompson JS, Dunlay SM, LaRue SJ, Lewis EF, Patel CB, Blue L, Fairclough DL, Leister EC, Glasgow RE, Cleveland JC, Phillips C, Baldridge V, Walsh MN, Matlock DD. Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device: The DECIDE-LVAD Randomized Clinical Trial. JAMA Intern Med. 2018 04 01; 178(4):520-529.
    View in: PubMed
    Score: 0.064
  52. Allen LA, Matlock DD, Shetterly SM, Xu S, Levy WC, Portalupi LB, McIlvennan CK, Gurwitz JH, Johnson ES, Smith DH, Magid DJ. Use of Risk Models to Predict Death in the Next Year Among Individual Ambulatory Patients With Heart Failure. JAMA Cardiol. 2017 04 01; 2(4):435-441.
    View in: PubMed
    Score: 0.060
  53. Bandle B, Ward K, Min SJ, Drake C, McIlvennan CK, Kao D, Wald HL. Can Braden Score Predict Outcomes for Hospitalized Heart Failure Patients? J Am Geriatr Soc. 2017 Jun; 65(6):1328-1332.
    View in: PubMed
    Score: 0.059
  54. Narayan M, Jones J, Portalupi LB, McIlvennan CK, Matlock DD, Allen LA. Patient Perspectives on Communication of Individualized Survival Estimates in Heart Failure. J Card Fail. 2017 Apr; 23(4):272-277.
    View in: PubMed
    Score: 0.059
  55. McIlvennan CK, Allen LA, Matlock DD. Caregiver Perspectives on End-of-Life Experiences of Patients With Left Ventricular Assist Devices-Reply. JAMA Intern Med. 2016 08 01; 176(8):1231-2.
    View in: PubMed
    Score: 0.057
  56. Magid M, McIlvennan CK, Jones J, Nowels CT, Allen LA, Thompson JS, Matlock D. Exploring cognitive bias in destination therapy left ventricular assist device decision making: A retrospective qualitative framework analysis. Am Heart J. 2016 10; 180:64-73.
    View in: PubMed
    Score: 0.057
  57. Paine AM, Allen LA, Thompson JS, McIlvennan CK, Jenkins A, Hammes A, Kroehl M, Matlock DD. Anchoring in Destination-Therapy Left Ventricular Assist Device Decision Making: A Mechanical Turk Survey. J Card Fail. 2016 Nov; 22(11):908-912.
    View in: PubMed
    Score: 0.056
  58. Magid M, Jones J, Allen LA, McIlvennan CK, Magid K, Thompson JS, Matlock DD. The Perceptions of Important Elements of Caregiving for a Left Ventricular Assist Device Patient: A Qualitative Meta-Synthesis. J Cardiovasc Nurs. 2016 May-Jun; 31(3):215-25.
    View in: PubMed
    Score: 0.056
  59. McIlvennan CK, Babu AN, Brieke A, Ambardekar AV. Concomitant surgical cryoablation for refractory ventricular tachycardia and left ventricular assist device placement: a dual remedy but a recipe for thrombosis? J Cardiothorac Surg. 2016 Apr 11; 11(1):53.
    View in: PubMed
    Score: 0.056
  60. Wordingham SE, McIlvennan CK, Dionne-Odom JN, Swetz KM. Complex Care Options for Patients With Advanced Heart Failure Approaching End of Life. Curr Heart Fail Rep. 2016 Feb; 13(1):20-9.
    View in: PubMed
    Score: 0.055
  61. Thompson JS, Matlock DD, McIlvennan CK, Jenkins AR, Allen LA. Development of a Decision Aid for Patients?With Advanced Heart Failure Considering a Destination Therapy Left?Ventricular Assist Device. JACC Heart Fail. 2015 Dec; 3(12):965-76.
    View in: PubMed
    Score: 0.055
  62. Magid KH, Matlock DD, Thompson JS, McIlvennan CK, Allen LA. The influence of expected risks on decision making for destination therapy left ventricular assist device: An MTurk survey. J Heart Lung Transplant. 2015 Jul; 34(7):988-90.
    View in: PubMed
    Score: 0.052
  63. Iacovetto MC, Matlock DD, McIlvennan CK, Thompson JS, Bradley W, LaRue SJ, Allen LA. Educational resources for patients considering a left ventricular assist device: a cross-sectional review of internet, print, and multimedia materials. Circ Cardiovasc Qual Outcomes. 2014 Nov; 7(6):905-11.
    View in: PubMed
    Score: 0.050
  64. Matlock DD, McIlvennan CK, Thompson JS, Morris MA, Venechuk G, Dunlay SM, LaRue SJ, Lewis EF, Patel CB, Blue L, Chaussee EL, Glasgow RE, Walsh MN, Allen LA. Decision Aid Implementation among Left Ventricular Assist Device Programs Participating in the DECIDE-LVAD Stepped-Wedge Trial. Med Decis Making. 2020 04; 40(3):289-301.
    View in: PubMed
    Score: 0.018
  65. Slavin SD, Allen LA, McIlvennan CK, Desai AS, Schaefer KG, Warraich HJ. Left Ventricular Assist Device Withdrawal: Ethical, Psychological, and Logistical Challenges. J Palliat Med. 2020 04; 23(4):456-458.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)